Liquidia Rallies to $34.05 as Investor Probe Revives Focus on the Yutrepia Patent Setback
Market Chameleon (Wed, 14-Oct 10:27 AM)
Market Chameleon (Tue, 13-Oct 11:28 AM)
Liquidia Faces Partial '327 Patent Loss as Court Finds Two Claims Valid and Infringed
Market Chameleon (Thu, 1-Oct 7:10 AM)
Liquidia Reports Surging Profitability on YUTREPIA Sales and Clinical Milestones in Q2 2026
Market Chameleon (Wed, 12-Aug 7:08 AM)
